Recent Articles from GlobeNewswire

WASHINGTON, March 31, 2025 (GLOBE NEWSWIRE) -- American Citizens Abroad, Inc. (ACA) today announced that it has engaged BGR Group as its new advocacy firm for federal affairs. BGR Group will support ACA’s legislative efforts including the upcoming debate regarding the Tax Cuts and Jobs Act (TCJA), which is up for extension this year. Specifically, ACA will be advocating to end the onerous double taxation of Americans living abroad.

New potentially life-saving solution aims to enhance combat communication and safety and will not require users to carry additional health monitoring equipment

WISeSat.Space Creates WISeSat España SA Subsidiary to Lead European Space Projects from Andalusia and Build a 100% “Made in Europe” Solution Aligned With the IRIS² Strategy

Partnership Leverages Creeksource’s Federal Contracting Advantage to Expand AI Security Solutions for DoD

VALENCIA, Spain, March 31, 2025 (GLOBE NEWSWIRE) -- iPronics, a leader in software-defined photonics, today launched its Optical Networking Engine, ONE-32, the world’s first Optical Circuit Switch (OCS) product based on silicon photonics. Tailored for AI workloads and energy-efficient cloud infrastructure, the ONE-32 delivers ultra-low latency, massive scalability, and groundbreaking cost efficiency, transforming data center networking.

BANGKOK, March 31, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that it has terminated the binding term sheet with healthcare company European Wellness Investment Holdings Limited (“EWIHL”) regarding their previously announced reverse merger transaction.

– The leading logistics provider demonstrates tailored LTL solutions can overcome common challenges for oversized, fragile, and “ugly” freight. —

QUEBEC CITY, March 31, 2025 (GLOBE NEWSWIRE) -- Robex Resources Inc. ("Robex" or the "Company") (TSXV: RBX) today reported its operational and financial results for 2024.

Fungi Meets Fashion: Hydefy Introduces a Durable, Versatile Alternative to Leather

Strategic alliance sets a new standard for media transparency and data-driven advertising

Turnkey “Flex Suite” System Elevates Customization While Simplifying Specification

Customer AI Agents help marketing teams launch 10X more personalization experiments and auto-optimize to customer outcomes.

Financial performance platform is now available in North America, the UK, Ireland, Australia, and New Zealand

MONTREAL, March 31, 2025 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (NYSE: CNI) will issue its first-quarter 2025 financial and operating results after the market close on May 1, 2025.

IRVINE, Calif. and CHICAGO, March 31, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, presented results from an expanded cohort of 500 patients in the ALIGN-AR Pivotal Trial for the Trilogy THV System in high-risk patients with symptomatic, severe aortic regurgitation (AR).

New partnership expands reporting platform’s data exchange to measure data integrity

Tivoxavir marboxil’s potential as a single dose therapeutic agent for bird flu supported by significant antiviral activity in three well accepted animal models and positive Phase 1 data

— Leading cloud services providers expand their adoption of EPYC CPUs to meet growing public cloud demand —

Strengthened leadership team with key appointments, including Barry Quart, Pharm.D. as CEO, and David Szekeres as President, bringing deep clinical, regulatory, operational and strategic expertise

Over 360 Burn Boot Camp locations in 44 states will come together to help raise money and awareness for the Muscular Dystrophy Association.

Integration of StormForge's ML-driven optimization capabilities into CloudBolt's award-winning FinOps platform to further reduce Insight-to-Action time in container environments

In a significant victory for Mullen and other emerging companies who have alleged losses due to stock manipulation, a federal judge denied IMC, Clear Street, and UBS’s motion to dismiss the lawsuit, finding Mullen’s claims were adequately pled.  The litigation will now move forward into full discovery

SINGAPORE, March 31, 2025 (GLOBE NEWSWIRE) -- SAIHEAT Limited (“SAIHEAT” or the “Company”) (NASDAQ: SAIH, SAITW), announces the sale of 40MW of cutting-edge liquid-cooling container products to one of the subsidiaries of Bitdeer Technologies Group (“Bitdeer”) (NASDAQ: BTDR). The liquid-cooling containers are designed to host Bitdeer’s high-performance SEALMINER mining rigs and will be deployed at Bitdeer’s new data center.

Richmond, Va, March 31, 2025 (GLOBE NEWSWIRE) -- Nationally recognized employee benefits and executive compensation attorney Robert M. Cipolla has joined Hunton Andrews Kurth LLP as a partner in Richmond, Virginia.

Solutions Drive Measurable Brand Lift and Business Outcomes for Advertiser Clients including  Mondelez, Post, and American Eagle Outfitters

Consumer Rewards App to Drive Market Research Innovation for German Brands and Retailers

PHILADELPHIA, March 31, 2025 (GLOBE NEWSWIRE) -- Holley Inc. (NYSE: HLLY) f/ka Empower Ltd. (NYSE: EMPW):

NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Antelope Enterprise Holdings Limited (NASDAQ Capital Market: AEHL) (“Antelope Enterprise”, “AEHL” or the “Company”), the majority interest owner of Kylin Cloud, a livestreaming e-commerce business in China, announced today certain changes to its Board of Directors. Effective March 24, 2025, its Board of Directors has appointed Ms. Ze Yang as a director of the Company's Board of Directors. Ms. Yang will serve as the chair of the audit committee, and a member of the compensation and nominating committees.

- Embraces Industry 5.0 with open, agile and resilient industrial processes integrating automation, energy management and digital technologies - Demonstrates an integrated approach showcasing how its solutions are shaping industry by connecting ecosystems- Enables manufacturers to be more competitive with AI-infused solutions for enhanced efficiency and innovation

Oak Brook, Illinois, March 31, 2025 (GLOBE NEWSWIRE) -- WittKieffer, the premier executive search and leadership advisory firm improving quality of life through impactful leadership, today announced the release of a new, comprehensive report on the healthcare CEO role. Based on original research and one-on-one dialogues with a cross-section of leading industry chief executives, "The Healthcare CEO Reimagined: Leading Healthcare's Next Chapter" offers a compelling and contemporary perspective on leadership paradigms; it delves into the evolving agenda of healthcare CEOs and explores how to prepare them for tomorrow’s challenges.

Montreal, Quebec, Canada, March 31, 2025 (GLOBE NEWSWIRE) -- In recognition of World Cloud Security Day on April 3rd, Genetec Inc. (“Genetec”), the global leader in enterprise physical security software, shares key insights and best practices to help organizations protect their data and operations from increasing cyber threats. With cyberattacks becoming more frequent and sophisticated, organizations must look beyond traditional cybersecurity solutions. A growing number of organizations are adopting cloud-based physical security solutions as part of a broader strategy to enhance cyber resilience. By moving critical systems and data to the cloud, businesses can ensure greater protection against vulnerabilities while minimizing the operational burden on IT teams.

NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, today announced an agreement with Eli Lilly and Company’s LillyDirect® pharmacy provider, Gifthealth, which will help streamline access to FDA-approved Zepbound® (tirzepatide) single-dose vials for Noom’s members with an on-label prescription from their physician.

Enhancing Gen Z Engagement Through AI-Driven Insights and Key Partnerships

Policy update increases access for millions covered by Evernorth Health Services

PHOENIX, March 31, 2025 (GLOBE NEWSWIRE) -- Global Water Resources, Inc. (NASDAQ: GWRS), a pure-play water resource management company, has declared under its dividend policy a monthly cash dividend in the amount of $0.02533 per common share (an annual dividend rate of $0.30396 per share).

Singapore, March 31, 2025 (GLOBE NEWSWIRE) -- HomesToLife Ltd (NASDAQ: HTLM) (“HomesToLife” or the “Company”), the holding company of one of the leading home furniture products retail chains in Singapore, today announced that it plans to issue its financial results release for the fiscal year ended December 31, 2024 on Monday, April 7 before the market opens, and hold a conference call to review the financial results on Friday, April 11 at 8:30 a.m. ET.

Strategic transaction combines industry-leading systems and rack-level expertise with AMD GPU, CPU and networking silicon and open-source software to address the $500 billion data center AI accelerator opportunity in 2028

FREMONT, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation (“Enovix”) (Nasdaq: ENVX), a global high-performance battery company, today announced the completion of its second milestone, triggering a payment for sample battery cells shipped under a development agreement executed in October 2024 with a leading smartphone OEM. The samples were customized to specific requirements of the OEM, including cycle life, fast charge and energy density levels which Enovix believes are superior to any product available on the market today.

BOSTON, March 31, 2025 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage biopharmaceutical company developing innovative therapeutics for rare diseases that affect bone health and blood vessel function, today announced that Doug Treco, Ph.D., CEO and Chairman of Inozyme, will participate in a fireside chat at the 24th Annual Needham Virtual Healthcare Conference on Monday, April 7, 2025, from 2:15-2:55pm ET.

ACESOT-1051 Trial Expanded to Include HPV+ Head and Neck Squamous Cell Carcinoma (HNSCC) Patients, Targeting Populations Most Likely to Benefit for WEEI Inhibition

NAPLES, Fla. and CAMBRIDGE, United Kingdom, March 31, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit Pharmaceuticals" or "Conduit" or the “Company”) today announces that the United States Patent and Trademark Office (USPTO) has granted the composition of matter patent for its lead asset, AZD1656, a Glucokinase Activator targeting autoimmune diseases, including Lupus and ANCA Vasculitis. With this critical composition of matter patent protection now secured, the Company is strategically positioned to advance AZD1656 into clinical development, with clinical trial plans now in final stages of preparation.

DENVER, March 31, 2025 (GLOBE NEWSWIRE) -- authID Inc. (NASDAQ: AUID) (“authID” or the “Company”), a leading provider of biometric identity verification and authentication solutions, today announced it has entered into a definitive agreement with investors to sell approximately 1,811,111 shares  of its common stock (the “Shares”) and/or Pre-Funded Warrants (the “Pre-Funded Warrants”), pursuant to a registered direct offering (the “Registered Direct Offering”). The purchase price for one Share or Pre-Funded Warrant will be $4.50, (each Pre-Funded Warrant will be exercisable into one share of common stock). The aggregate gross proceeds from the Offering are expected to be approximately $8,150,000 million before deducting placement agent fees and other offering expenses.

SINGAPORE, March 31, 2025 (GLOBE NEWSWIRE) -- GCL Global Holdings Ltd (NASDAQ: GCL) (“GCL” or the “Company”), a leading provider of games and entertainment, and the Hainan Animation and Gaming Association (“the Association”), a key industry organization in the animation and gaming sector in Hainan, China, today announced the signing of a non-binding memorandum of understanding (the “MOU”) for a proposed long-term strategic partnership to accelerate the development of the animation and gaming industry in China’s Hainan province.

SOUTH SAN FRANCISCO, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms, announces that the Company has received clearance by the U.S. Food and Drug Administration (FDA) for a second Investigational New Drug (IND) application for lead compound CER-1236 for a Phase 1 clinical trial in advanced solid tumors, specifically non-small cell lung cancer and ovarian cancer.

Voltus completes integration and submits DER Participation Model registrations in National Grid’s territory

Two large studies of over one million patients reveal that short-term Holter-duration monitoring frequently misses actionable arrhythmias and that patient-reported symptoms are an unreliable predictor of arrhythmic events

WESTLAKE VILLAGE, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ Global Market: NTHI), a clinical-stage medical biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation (RPDD) to perillyl alcohol (NEO100™) for the treatment of pediatric-type diffuse high-grade gliomas, a serious and life-threatening condition affecting children and adolescents.

NoPorts Now Makes Private Websites Invisible to Attackers and Accessible Only Through Cryptographically Authenticated Connections

CERRITOS, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today proudly announced the launch of the Florida Oncology Network. This new fully delegated network will expand access to high-quality, coordinated cancer care for Florida residents.

FOSTER CITY, Calif. and TAIPEI, Taiwan, March 31, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics”), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, and LaunXP International Co., Ltd., an affiliate of LaunXP Biomedical Co., Ltd. (TWO: 6876) (“LaunXP”), announced today that the parties have entered into an agreement for the development and commercialization in Asia (excluding mainland China, Hong Kong and Macau) (the “LaunXP Territory”) of vebreltinib, Apollomics’ proprietary c-Met inhibitor, in combination with an EGFR inhibitor (“EGFRi”) for the treatment of NSCLC. The EGFRi class of targeted kinase inhibitors is currently a foundational targeted therapy for the treatment of NSCLC and other tumor types.

TORONTO, March 31, 2025 (GLOBE NEWSWIRE) -- Clip Money Inc. (TSX-V: CLIP; OTCQB: CLPMF) (“Clip Money” or the “Company”), a company that operates a multi-bank self-service deposit system for businesses, is pleased to announce its financial results for the fiscal year ended December 31, 2024. The Company reported record revenue growth in 2024, up over 300% from 2023. Whereas, Cost of Revenues were up only 37% during the same time period, demonstrating strong operating leverage that is expected to continue in 2025.

DALLAS, March 31, 2025 (GLOBE NEWSWIRE) -- Veritex Holdings, Inc. (Nasdaq: VBTX) (“Veritex” or "the Company”), the parent holding company for Veritex Community Bank, today announced that its Board of Directors (the "Board") authorized the extension of the stock buyback program (the "Stock Buyback Program") through March 31, 2026, pursuant to which the Company is authorized to purchase up to $50.0 million shares of the Company’s outstanding common stock. To date, the Company has repurchased 555,016 shares, or $13.1 million under the Stock Buyback Program. The Stock Buyback Program may be suspended, terminated, amended or modified by the Board at any time without prior notice at the Board’s discretion. The Stock Buyback Program was originally approved by the Board in 2024 and was set to expire on March 31, 2025. Other than the extension of the Stock Buyback Program for an additional year, no changes were made to the Stock Buyback Program.

-- Randomized 87 patients to date in Phase 2b CHASE trial of KPI-012 in Persistent Corneal Epithelial Defect (PCED) --

VANCOUVER, British Columbia, March 31, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company, is pleased to announce it has appointed Dr. Steven Sangha to its Board of Directors. Dr. Sangha has over 25 years of business experience, including investment banking, business development and asset management. His extensive background with public company governance, compliance and finance has led him to run a successful Private Fund Family Office.

Emerges as a privately held company, with long-term financing to accelerate development of the BioJet™ platform

Recorded noted regulatory successes with FDA general use clearance and granting of CE Mark in the EU

WATERTOWN, Mass., March 31, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body’s immune system for the treatment of cancer and other immune-mediated conditions, today announced that Daniel J. Hicklin, Ph.D., President and Chief Executive Officer and Randi Isaacs, M.D., Chief Medical Officer, both of Werewolf Therapeutics, will present a corporate overview at 1:30 PM ET on Monday, April 7, 2025, at the 24th Annual Needham Virtual Healthcare Conference, taking place on April 7–10, 2025.

RESTON, Va., March 31, 2025 (GLOBE NEWSWIRE) -- Tax season is a prime time for criminals to exploit weak identity security and commit fraud. Millions of Americans still rely on their Social Security Number (SSN) to file taxes, leaving them vulnerable. To protect taxpayers, Regula has launched the Tax Fraud Awareness Guide.

LONDON and NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP), a severe ocular condition without an FDA approved therapy, and for inflammatory dry eye disease (DED), a multi-billion-dollar market, is pleased to announce that the Company has successfully established that urcosimod (formerly known as OK-101) has been shown to be stable for over two and a half years in single-use ampoules used for administration of the drug to patients. Urcosimod is presently in a Phase 2b, randomized, placebo-controlled, double-masked, 48-patient clinical trial to treat NCP patients.

CAMBRIDGE, Mass., March 31, 2025 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer, today announced its participation in upcoming investor conferences. Presentation details with President and Chief Executive Officer, Mark Velleca, M.D., Ph.D., are as follows:

WILMETTE, Ill., March 31, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for patients with unmet medical needs, today announced fourth quarter and full-year 2024 financial results and summarized recent developments.

DJT Stock Will Be First Listing on New Texas Exchange

Annual channel awards program honors Rapid7 partners’ excellence in cybersecurity product and services delivery, customer retention, and more

– Data Further Advance Understanding of VASCEPA®/VAZKEPA® Potential Mechanism of Action and Utility as A Complementary Therapy for Residual Risk Reduction in Combination with Statins in Important Patient Sub-Categories –

GAITHERSBURG, Md., March 31, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that its Board of Directors has authorized the repurchase of up to $50 million of the company’s common stock on or before March 27, 2026.

- Durability Results from BOND-003 data will be presented as a late breaker as part of AUA’s Practice-changing, Paradigm-shifting Clinical Trials in Urology -

NAARDEN, the Netherlands and MIAMI, March 31, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that Ian Somaiya, Chief Financial Officer of NewAmsterdam Pharma, will participate in a virtual fireside chat at the 24th Annual Needham Virtual Healthcare Conference on Monday, April 7, 2025 at 12:45 p.m. ET.

BEIJING, March 31, 2025 (GLOBE NEWSWIRE) -- Luckin Coffee Inc. (“Luckin Coffee” or the “Company”) (OTC: LKNCY) today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 (the “2024 Annual Report”) with the U.S. Securities and Exchange Commission (the “SEC”).

EDMONTON, Alberta, March 31, 2025 (GLOBE NEWSWIRE) -- Regenx Tech Corp. (the "Company" or "Regenx") (TSXV: RGX) (OTCQB: RGXTF) (FSE: YRS WKN: A2DSW3) announces the Company has received unsecured and non-brokered financing for gross proceeds of $679,032 in Debenture Financing. The debentures will bear interest at the rate of 15%-25% per annum. The Subscriber will also be issued 500 warrants for each $1,000 Debenture. Each warrant allows the Subscriber to purchase a common share of the Corporation for $0.05 per share if exercised prior to the expiry date of December 31, 2025. The Corporation can redeem the Debentures at any time upon 10 days prior written notice. The Company intends to use the proceeds to support operations, and general working capital.

COOTAMUNDRA, Australia, March 31, 2025 (GLOBE NEWSWIRE) -- Australian Oilseeds Holdings Limited, a Cayman Islands exempted company (the “Company”) (NASDAQ: COOT) today announced financial results for its second quarter fiscal 2025 ended December 31, 2024.

Key Executive Hires Accelerate Growth Strategy and Enhance Security Intelligence Capabilities

WEST CHESTER, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that Jayson Rieger, PhD, MBA, President and Chief Executive Officer of Verrica Pharmaceuticals, will participate in a fireside chat at the 24th Annual Needham Virtual Healthcare Conference.

Angels for Sight State-of-the-Art Vision Clinic for the Underserved Opens in Long Beach, California

Intetics, a leading global technology company, has once again been recognized by Fortune as one of America’s Most Innovative Companies in 2025.